Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HiLo-Trial: Higher Versus Lower Oxygen Concentration for Resuscitation in Very Low Birthweight Infants
NCT03825835Active, not recruiting
- Sponsor
- University of Alberta
- Start
- Jun 2022
- Primary completion
- Sep 2028
- Modality
- Inhalation Devices
- Countries
- 2
01
Overview
Randomised, open-label trial of oxygen in respiratory distress syndrome (RDS) (2 arms), sponsored by University of Alberta. Primary endpoint: Composite outcome of all-cause mortality or the presence of a major neurodevelopmental outcomes at 24 months. Started Jun 2022; status: active, not recruiting.
02
Drugs
oxygen
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on NCT03825835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03825835.